Association Between Hemoglobin Levels and Efficacy of Intravenous Ferric Carboxymaltose in Patients With Acute Heart Failure and Iron Deficiency: An AFFIRM-AHF Subgroup Analysis

BACKGROUND: Iron deficiency, with or without anemia, is an adverse prognostic factor in heart failure (HF). In AFFIRM-AHF (a randomized, double-blind placebo-controlled trial comparing the effect of intravenous ferric carboxymaltose on hospitalizations and mortality in iron-deficient subjects admitt...

Descripción completa

Detalles Bibliográficos
Autores principales: Filippatos, Gerasimos, Ponikowski, Piotr, Farmakis, Dimitrios, Anker, Stefan D., Butler, Javed, Fabien, Vincent, Kirwan, Bridget-Anne, Macdougall, Iain C., Metra, Marco, Rosano, Giuseppe, Ruschitzka, Frank, van der Meer, Peter, Wächter, Sandra, Jankowska, Ewa A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
Original Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10487376/
https://www.ncbi.nlm.nih.gov/pubmed/37051919
http://dx.doi.org/10.1161/CIRCULATIONAHA.122.060757

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10487376/
https://www.ncbi.nlm.nih.gov/pubmed/37051919
http://dx.doi.org/10.1161/CIRCULATIONAHA.122.060757

Ejemplares similares